Clinical Trials Browser

Phase 1/2 × OTHER × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT01757626 2026-01-07

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Phase 1/2 Active not recruiting

186 enrolled 2 FDA

Neuroblastoma

NCT06626516 2025-11-28

Tebentafusp-tebn With LDT in Metastatic UM

Phase 1/2 Recruiting

Uveal Melanoma, Melanoma

NCT01064375 2022-08-19

El-porCEA

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT05131711 2021-11-23

CSREIG

Phase 1/2 Unknown

Glioblastoma

NCT02009397 2021-11-22

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

Phase 1/2 Completed

27 enrolled 5 charts

Melanoma

NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT02173093 2019-01-29

Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

Phase 1/2 Unknown

Neuroblastoma

NCT03282188 2018-05-04

REO13 Melanoma With of Without GM-CSF

Phase 1/2 Withdrawn

Melanoma, Skin Neoplasms

NCT02429440 2017-08-17

UroRCC

Phase 1/2 Unknown

Carcinoma, Renal Cell

NCT02452307 2017-08-17

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

Phase 1/2 Unknown

Prostatic Neoplasms

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00429416 2016-11-29

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Phase 1/2 Completed

14 enrolled 11 charts

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT00089219 2014-11-20

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma

NCT00939510 2013-01-31

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Phase 1/2 Completed

32 enrolled 9 charts

Prostatic Neoplasms